Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
CANVAS (canagliflozin) reported an HR of 1.7 (95% CI 1.51, 1.91) for regression of albuminuria and a 40% reduction in risk in the composite outcome of eGFR, ESRD or renal death (5.5 vs 9.0 participants per 1000 patient-years
In the SURMOUNT-1 trial, tirzepatide (Zepbound) at its highest dose produced an average body weight reduction of 20.9% over 72 weeks
L-carnitine operates downstream in mitochondria, shuttling stored fat into the cellular powerhouse where it burns for energy
The safest path forward involves medical supervision and careful planning of the transition period
US$ 25.30
US$ 22.26
US$ 24.28
US$ 29.38
US$ 20.30
US$ 28.90
US$ 21.24
US$ 24.10
US$ 23.07
US$ 24.22
US$ 27.33
US$ 22.04
US$ 20.17
US$ 27.29
US$ 27.19
